We respect your privacy. Please consent to all cookies when you visit our website. Refer to our "Privacy Policy" for more information on how we handle personal data.

d1bannerpc119.jpg d1_banner_pc.jpg

Milestone Pharma

A Pharmaceutical Quality Research CRO.

Submission-ready analytical, impurity, and CMC quality solutions built for global filings.

Milestone Pharma

Milestone Pharma supports global pharma and biotech teams with pharmaceutical quality research across analytical development, impurity and nitrosamine/NDSRI studies, E&L/CCIT, and reference standards. Our focus is simple: deliver reliable, regulatory-aligned data you can use for decisions and filings.

Milestone Pharma is a professional pharmaceutical quality research CRO. Guided by Science Enables Better Medicines, Technology Shapes Standards, we provide one-stop CMC, analytical and impurity solutions supporting FDA, EMA, NMPA global submissions.

With CNAS-accredited labs in Nanjing and Shanghai, we ensure data integrity and regulatory compliance. We have served 2,500+ global clients and delivered 10,000+ projects, covering small molecules, TIDES, biologics, nanomedicines, ATMP and drug-device systems.

We accelerate drug development and secure global market access for partners.

about us-overview_2x.webp
d1imghz.png

Key Metrics

  • 10 +
    years of experience
  • 290 +
    scientists & engineers
  • 2500 +
    global customers
  • 10000 +
    projects delivered
Development history

Development History

2016

Founded in Nanjing


2018

Shanghai site established

2021-2022

CNAS (ISO/IEC 17025) accreditation (Nanjing & Shanghai)


2023

Passed FDA on‑site inspection

(Nanjing & Shanghai)


2025

Passed FDA inspection again EU‑QP audits  CFDI inspections


Corporate Culture

  • about us - culture_01_2x.webp

    VISION

    To provide comprehensive services for global customers to improve the quality standards of pharmaceutical and healthcare products.

  • about us - culture_02_2x.webp

    MISSION

    Continue building a quality research and development technology platform in line with global drug regulations and become industry leader to provide the best quality of services with the most complete capabilities and the best technologies.

  • about us - culture_03_2x.webp

    VALUES

    • Integrity & Dedication

    • Working Together & Sharing Success

    • Doing the Right Thing

    • Doing It Right

Corporate Hornor

  • 2025
  • 2023
  • 2022
  • 2021
2025
  • 微信图片_20260629114012_7078_866.jpg

    • Passed the on-site audit for EU Qualified Person Compliance Statement

    • Re-passed FDA inspection

    • Updated CNAS test items for the 2025 Chinese Pharmacopoeia

    • Completed CNAS accreditation expansion for medical devices

2023
  • 微信图片_20260629114009_7077_866.jpg

    • Passed FDA GMP inspection at laboratories in Shanghai and Nanjing

    • Obtained filing certificate for Shanghai pathogenic microorganism laboratory, BSL-2 level


2022
  • 微信图片_20260629114012_7078_866.jpg

    • Obtained CNAS accreditation (Shanghai site) , Certificate No. CNAS L17395

2021
  • 微信图片_20260629113958_7075_866.jpg

    • Obtained CNAS accreditation (Nanjing site), Certificate No. CNAS L11112

Discuss My Project

Speak with an expert about your upcoming project to see how we can help you.